• When 7-9 September, 2026
  • Where InterContinental Barcelona
  • Search

Accelerate funding, partnerships, and commercialisation

Advanced Therapies Europe connects clinical-stage and scaling biotechs with active investors, pharma, and CDMOs to move programmes forward, fast.

✅ 996 pre-arranged meetings.
✅ $1bn+ in investor capital.
✅ Curated 1:1 partnering designed for outcomes.


A strictly curated audience of 600 ensures you meet decision-makers, not just attendees.

Apply to attend

Competing in today’s European CGT market

Europe’s CGT market is shifting fast. The focus has moved from early science to commercial execution, and the gap between those who can scale and those who can’t is widening. Regulatory change, global competition, and tighter capital mean biotechs like you are under pressure to move faster, prove value earlier, and build the right partnerships from day one.

  • Europe is advancing, but still lags the US in commercialisation and China in trial speed and cost efficiency
  • Investors are prioritising clinically validated, commercially viable assets, not early-stage science alone
  • New frameworks like Joint Clinical Assessments are raising the bar for evidence, access, and pricing strategy

This is where ATE becomes commercially critical: 

Secure capital in a selective market

Meet investors actively deploying into clinically validated, commercially viable programmes

Build the right partnerships early

Connect with pharma, CDMOs, and tech partners aligned to your stage, manufacturing strategy, and scale-up needs

Navigate regulatory and access complexity

Gain practical insight into JCA, pricing, and evidence expectations, so you can plan smarter from day one

Move faster with the right conversations already in place

996 pre-arranged, concierge-led meetings ensure your time is spent advancing deals, not finding them

Key Agenda Themes in 2026

  • From pipeline to product - Europe is moving toward commercialisation. ATE connects you with partners, capital and expertise to turn clinical progress into executable plans and real market pathways.
     

  • Funding in a constrained market - Meet active investors and understand what gets deals done today, helping you position your programme to secure funding in a volatile investment environment.
     

  • Partnering that drives execution - Engage pharma, CDMOs and service leaders in structured meetings designed for outcomes. A curated audience ensures conversations are relevant, focused and commercially aligned.

  • Navigating European complexity - Gain practical insight on pricing, access and manufacturing across fragmented markets. Learn how others are overcoming barriers and where opportunities exist to move faster.
     

  • Scaling beyond clinical success - Explore how to build toward launch, scale manufacturing and prepare for reimbursement realities. Learn from those who have done it and avoid costly delays.


    View the Agenda

Built for Biotechs Ready to Scale

If you’re preparing for your next funding round, strategic partnership, or commercial milestone, this is where those conversations move forward. Designed for clinical-stage and scaling biotechs, Advanced Therapies Europe gives you direct access to the capital, partners, and insight needed to move from progress to execution.

If you’re evaluating where to spend your time and budget this year, this gives you a clear view of the return.

The Delegate Pack shows you who’s in the room, what conversations are happening, and how to make your time count, before you decide to attend.

Inside the delegate pack:

  • A breakdown of attending investors, pharma, and biotech companies
  • Insight into the types of deals, partnerships, and conversations happening
  • How the 1:1 meeting concierge works and how you’re matched
  • An overview of the agenda, themes, and key discussion area
     

Download the Delegate Pack

Who Might You Find On the Show Floor?

2025 Attendee List 2025 Exhibitor List

600
CGT Leaders
40+
Countries
100000000
EUR Capital Represented
1000+
1:1 Partner Meetings

 

  • "What an incredible few days at the ATE conference by Phacilitate! Grateful for the power of my network and the opportunity to meet so many familiar faces while growing it further.”
    Head of Business Development: Cell Therapy and Laboratory Services | Cell and Gene Therapy
  • “Impactful moments and connections.”
    Director Global Cell and Gene Therapies Portfolio Management | EMBA | Deep Tech
  • “Already having fantastic conversations here at ATE24 in Lisbon.”
    Experienced Leader in Cell and Gene Therapy Business and Commercial Strategy